Aktie A40BYY SYNCOM FORMULATIONS (INDIA) LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Syncom Formulations (India) Limited

Aktien

A40BYY

INE312C01025

SYNCOMF

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:48 17.05.2024 		% 5 Tage % 1. Jan.
13,44 INR -0,59 % Intraday Chart für Syncom Formulations (India) Limited +2,99 % -10,64 %
29.03. Syncom Formulations (India) Limited kündigt Änderungen im Vorstand an CI
14.02. Syncom Formulations (India) Limited meldet Gewinnergebnisse für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Syncom Formulations Limited Announces Board Changes
Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Syncom Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Syncom Formulations Begins Commercial Production at Expanded Plant in Pithampur, India
Syncom Formulations Limited Commences Commercial Production
Syncom Formulations Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Syncom Formulations Limited Announces Commercial Production Starts from 30 June 2023
Syncom Formulations Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Syncom Formulations Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Syncom Formulations Limited Announces Executive Changes
Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Syncom Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Syncom Formulations Limited Approves the Declaration of Dividend for the Financial Year Ended 31 March 2022
Syncom Formulations Sees Delay in Completion of Expansion Project
Syncom Formulations Limited Announces Updates on its Project for Expansion Cum Modernisation of Existing Plant at Pithampur
Syncom Formulations Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Syncom Formulations Limited Appoints Ruchi Jindal as an Additional Director
Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Syncom Formulations Limited Announces Executive Changes
Syncom Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A40BYY Aktie
  4. Nachrichten Syncom Formulations (India) Limited
  5. Andere Sprachen